167 related articles for article (PubMed ID: 16014372)
21. Xeloda. Warning: drug interaction increase bleeding risks.
Nursing; 2002 Mar; 32(3):26. PubMed ID: 11902039
[No Abstract] [Full Text] [Related]
22. [A case of relapsed colon cancer successfully treated by capecitabine].
Hashimoto T; Yokoyama M; Kimura S; Usuba O; Toyono M
Gan To Kagaku Ryoho; 2013 Apr; 40(4):523-7. PubMed ID: 23848025
[TBL] [Abstract][Full Text] [Related]
23. Capecitabine-induced severe hypertriglyceridemia: report of two cases.
Kurt M; Babaoglu MO; Yasar U; Shorbagi A; Guler N
Ann Pharmacother; 2006 Feb; 40(2):328-31. PubMed ID: 16391007
[TBL] [Abstract][Full Text] [Related]
24. Capecitabine-induced potentiation of warfarin.
Buyck HC; Buckley N; Leslie MD; Plowman PN
Clin Oncol (R Coll Radiol); 2003 Aug; 15(5):297. PubMed ID: 12924461
[No Abstract] [Full Text] [Related]
25. Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.
Lee JJ; Kim TM; Yu SJ; Kim DW; Joh YH; Oh DY; Kwon JH; Kim TY; Heo DS; Bang YJ; Kim NK
Jpn J Clin Oncol; 2004 Jul; 34(7):400-4. PubMed ID: 15342667
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer.
Lamberti C; Sauerbruch T; Glasmacher A
Cancer Treat Rev; 2005 Dec; 31(8):648-52. PubMed ID: 16289340
[No Abstract] [Full Text] [Related]
27. Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature.
Bar-Sela G; Haim N
Cancer Chemother Pharmacol; 2009 Apr; 63(5):779-82. PubMed ID: 18641989
[TBL] [Abstract][Full Text] [Related]
28. [Study of tolerability of capecitabine in postoperative adjuvant chemotherapy in colon cancer].
Matsuda C; Tamagawa H; Nishikawa K; Deguchi T; Kawata J; Iwase K; Takagi M; Fukui A; Nezu R; Tanaka Y
Gan To Kagaku Ryoho; 2013 Mar; 40(3):327-30. PubMed ID: 23507593
[TBL] [Abstract][Full Text] [Related]
29. Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness.
Twelves CJ
Clin Colorectal Cancer; 2006 Nov; 6(4):278-87. PubMed ID: 17241512
[TBL] [Abstract][Full Text] [Related]
30. [Ileitis following capecitabine use].
Bouma G; Imholz AL
Ned Tijdschr Geneeskd; 2011; 155():A3064. PubMed ID: 21486509
[TBL] [Abstract][Full Text] [Related]
31. Medullary thyroid cancer treated by capecitabine.
Labidi SI; Gravis G; Tarpin C; Brun V; Viens P
Anticancer Drugs; 2007 Aug; 18(7):831-4. PubMed ID: 17581307
[TBL] [Abstract][Full Text] [Related]
32. A retrospective observational study on the use of capecitabine in patients with severe renal impairment (GFR <30 mL/min) and end stage renal disease on hemodialysis.
Jhaveri KD; Flombaum C; Shah M; Latcha S
J Oncol Pharm Pract; 2012 Mar; 18(1):140-7. PubMed ID: 22392964
[TBL] [Abstract][Full Text] [Related]
33. Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient.
Aksoy S; Karaca B; Dinçer M; Yalçin S
Ann Pharmacother; 2005 Mar; 39(3):573-4. PubMed ID: 15701780
[No Abstract] [Full Text] [Related]
34. Critically elevated INR in a patient on warfarin after increase in extended-release niacin dose.
Christopher A
Ann Pharmacother; 2011 Nov; 45(11):e58. PubMed ID: 22010004
[TBL] [Abstract][Full Text] [Related]
35. A phase I study of capecitabine, oxaliplatin, and lapatinib in metastatic or advanced solid tumors.
Dennie TW; Fleming RA; Bowen CJ; Dar MM; Alberti D; Oliver K; Loconte N; Mulkerin D; Holen KD
Clin Colorectal Cancer; 2011 Mar; 10(1):57-62. PubMed ID: 21609937
[TBL] [Abstract][Full Text] [Related]
36. Transient elevation of international normalized ratio during cisplatin-based chemotherapy in patients who are taking warfarin.
Yano R; Kurokawa T; Tsuyoshi H; Shinagawa A; Sawamura Y; Matsunaga A; Nakamura T; Yoshida Y; Yoneda M; Kotsuji F; Masada M
Ann Pharmacother; 2011 Oct; 45(10):e55. PubMed ID: 21881031
[TBL] [Abstract][Full Text] [Related]
37. Capecitabine cardiotoxicity--case reports and literature review.
Manojlovic N; Babic D; Stojanovic S; Filipovic I; Radoje D
Hepatogastroenterology; 2008; 55(85):1249-56. PubMed ID: 18795667
[TBL] [Abstract][Full Text] [Related]
38. Toxicity profile and efficacy of oral capecitabine as adjuvant chemotherapy for Chinese patients with Stage III colon cancer.
Law CC; Fu YT; Chau KK; Choy TS; So PF; Wong KH
Dis Colon Rectum; 2007 Dec; 50(12):2180-7. PubMed ID: 17963003
[TBL] [Abstract][Full Text] [Related]
39. Interaction between gemfibrozil and warfarin: case report and review of the literature.
Dixon DL; Williams VG
Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
[TBL] [Abstract][Full Text] [Related]
40. Probable drug interaction between warfarin and hormonal contraceptives.
Zingone MM; Guirguis AB; Airee A; Cobb D
Ann Pharmacother; 2009 Dec; 43(12):2096-102. PubMed ID: 19934391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
